arrow
M

Maeva Dufies

université côte d'azur
H指数:31
被引数:2,379

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Connective tissue growth factor contributes to resistance to anti-angiogenic therapies in renal cancer

结缔组织生长因子导致肾癌对血管生成抑制治疗的耐药性

2026-01-010
PRE
Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation

抑制USP39去泛素化酶功能通过ZEB1降解损害多发性骨髓瘤细胞的生存和迁移

2024-12-301
OA
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001
2024-03-196
OAAI
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression
2021-10-2022
OAAI
Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
2021-02-0532
OAAI
Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma

可溶性形式的PD-L1和PD-1作为舒尼替尼对转移性透明细胞肾细胞癌患者疗效的预后和预测标志物

2020-11-2533
OAAI
PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
2019-07-0131
OAAI
UBTD1 is a mechano-regulator controlling cancer aggressiveness
2019-02-2524
OAAI
Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma

可溶性CD146是透明细胞肾细胞癌中贬义性进化和舒尼替尼疗效的预测标志物

2018-01-0117
OAAI
In Vitro and in Vivo Evaluation of Fully Substituted (5-(3-Ethoxy-3-oxopropynyl)-4-(ethoxycarbonyl)-1,2,3-triazolyl-glycosides as Original Nucleoside Analogues to Circumvent Resistance in Myeloid Malignancies
2017-02-0242
PREAI